GHK-Cu monograph

GHK-Cu Monograph

^[1]

This page preserves the structured raw monograph for TroponinIQ Base under the shared content policy. The content is factual reference material; it is not a production prompt or constant update. No Production target: directive was present in the source.

Curation Summary

• Class: Copper-binding tripeptide complex / cosmetic peptide
• Legal/regulatory status: FDA has not approved GHK-Cu as a drug. FDA compounding documentation states 'GHK-Cu (except for injectable routes of administration)' will be added back to Category 1 for bulk substances considered for compounding, which indicates injectable routes are excluded from that current listing. I found no evidence that GHK-Cu is specifically listed as a WADA prohibited substance, but absence from the list is not the same as endorsement. In practice, performance-oriented systemic use is regulatory gray territory and often treated as a research-chemical/compounding issue.
• Routing: module 03 knowledge for mechanism, clinical/performance context, legal status, safety, and FAQ retrieval.
• Source hash: 081fe2e1c04b739fa50e9d5d03510e3a44e9a6a8cdea7e4ce6fbe329354d4b6e